Pharmagreen Biotech

Early Stage

The Future of Planting is Tissue Culture

Analytics

Raised to Date: Raised: $100,000

Aggregate Commitments $

Platform

Dalmore Group

Start Date

09/27/2021

Close Date

10/31/2021

Min. Goal

$1,000

Max. Goal

$7,500,000

Min. Investment

$1,000

Security Type

Equity - Common

Funding Type

RegA+

Price Per Share

$0.03

Rolling Commitments $

Status
Funded
Reporting Date

10/31/2021

Days Remaining
Funded
% of Min. Goal

10,000%

% of Max. Goal

1%

Likelihood of Max
Funded
Avg. Daily Raise

$2,941

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

COQUITLAM, British Columbia

Industry

Alcohol, Tobacco, & Recreational Drugs

Tech Sector

Biotech

Pharmagreen Biotech is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use innovative tissue culture technology for the preservation of plant species. Pharmagreen Biotech uses tissue culture science to make the highest quality, disease-free, and genetically same plantlets of high CBD hemp. The optimised plant growth technology of Pharmagreen eliminates disease and contamination, reduces growing time, and assures high-quality products. Peter Wojcik founded Pharmagreen Biotech in 2007. The current crowdfunding campaign has no minimum target and a maximum target of $7,500,000. The campaign proceeds will be used for real property lease or acquisition, equipment, construction costs, working capital, and general and administrative expenses.

Balance Sheet

Cash and Cash Equivalents

$29,764

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$0

Loans

$0

Property, Plant and Equipment (PP&E)

$0

Property and Equipment

$0

Total Assets

$283,688

Accounts Payable & Accrued Liabilities

$576,836

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$0

Total Liabilities

$2,036,940

Total Stockholders' Equity

$-1,753,252

Total Liabilities and Equity

$283,688

Statement of Comprehensive Income Information

Total Revenues

$0

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$101,624

Total Interest Expenses

$0

Depreciation and Amortization

$0

Net Income

$-101,624

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: Saturna Group Chartered Professional Accountants LLP
Financials as of: 09/27/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Pharmagreen Biotech on Dalmore Group 2022
$
Platform: Dalmore Group
Security Type: Equity - Common

Follow company

Follow Pharmagreen Biotech on Dalmore Group 2022
View on Dalmore Group (Closed)
Bullish / Bearish
You're Bullish on Pharmagreen Biotech on Dalmore Group 2022

Thank you for your vote on Pharmagreen Biotech on Dalmore Group 2022

Bullish / Bearish
You're Bearish on Pharmagreen Biotech on Dalmore Group 2022

Thank you for your vote on Pharmagreen Biotech on Dalmore Group 2022